CompaniesMarket WrapPrint articleBiotech misses the markThe budding biotech has endured one of its worst weeks in its history as the stock collapsed a record 32.7 per cent on Wednesday.Brendon LauUpdated Jun 26, 2010 – 3.50pm, first published at Jun 25, 2010 – 2.31pmSaveLog in or Subscribe to save articleShareCopy linkCopiedEmailLinkedInTwitterFacebookCopy linkCopiedShare via...Gift this articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? LoginPharmaxis (PXS)The budding biotech has endured one of its worst weeks in its history as the stock collapsed a record 32.7 per cent on Wednesday on worries that its key drug Bronchitol would not be approved by US medical regulators.Loading...SaveLog in or Subscribe to save articleShareCopy linkCopiedEmailLinkedInTwitterFacebookCopy linkCopiedShare via...Gift this articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? LoginLicense articleIntroducing your NewsfeedFollow the topics, people and companies that matter to you.Find out moreRead MoreMarket WrapCeramic Fuel CellsElders LimitedFlexigroup LimitedPharmaxis LtdLatest In CompaniesFetching latest articlesMost Viewed In Companies